Search

everythinglearnresearchcommunity

for

Search:↓

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

CT scans can find serious prostate cancer even when PSA levels are low.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Using a laser to remove hair in the urethra after hypospadias repair is effective and minimally invasive.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Testosterone creams and gels can be effective but have serious risks and should be used only with medical supervision.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Hair transplantation for men has improved, offering natural, lasting results, and may be enhanced by certain medications and future technologies.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Serum triglyceride levels are not linked to prostate cancer risk.

Higher cholesterol levels increase aggressive prostate cancer risk.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride may reduce bleeding after TURP, but more research needed.